HMPV Rapid Surge in China: Is History Repeating?

HMPV Rapid Surge in China: Is History Repeating?
HMPV Rapid Surge in China: Is History Repeating?

United States: There seems to be an upward surge of respiratory viruses in China, which has caused people to state that hospitals are saturated, there are new checkpoints and identification methods, and there is an outbreak threat.

More about the news

The virus named human metapneumovirus (HMPV) has been claiming the lives of many people in the northern provinces this winter, especially children.

It was formed five years after the world began receiving signals of a new species of the coronavirus from Wuhan in China, which has affected more than seven million people, with deaths recorded worldwide.

Bureaucracies in charge of containing diseases are coming up with frameworks to control the emergence of acute respiratory diseases of an unspecified nature.

However, Beijing has dismissed the incidents as a normal feature of winter business.

According to a spokesperson from China’s foreign ministry, Mao Ning, on Friday, “Respiratory infections tend to peak during the winter season, and The diseases appear to be less severe and spread with a smaller scale compared to the previous year,” Independent News reported.

About HMPV

HMPV stands for Human metapneumovirus, a respiratory virus that may be symptomized like the common cold or influenza.

Although most common in toddlers, the flu could cause dangerous complications, including pneumonia in infants, the elderly, and those with compromised immune systems.

It emerged positive for the virus, which is not new but has recently come into the limelight with the onset of new cases in children, most especially those below 14 years in the northern part of China.

HMPV was first reported in 2001; it is a single-stranded RNA virus that is transmitted through respiratory droplets or contact with surfaces contaminated with the virus.

A similar case has been described in the past in other countries, such as the United Kingdom, as reported by Independent News.

It has signs of cough, fever, nasal congestion, and fatigue, and it has a period of communicability of three to six days.

It differs from Covid-19 in that no vaccine or antiviral therapy is specifically used in the treatment of HMPV; instead, symptoms are treated.

Again, these are the prevalent weather conditions that often lead to increased rates of transmission of respiratory diseases, including influenza.

Government health officials note that this increase has been seen as typical at the beginning of a new year.

China’s National Disease Control and Prevention Administration also recently noted the high incidence of respiratory infections, HMPV included, during winter.

As per the World Health Organisation (WHO), the situation is not as bad as to declare it as a global health emergency. However, the rise in cases has led the authorities to ramp up monitoring systems.